1.0Leitat Technological Centerhttps://leitat.org/en/Comunicación Leitathttps://leitat.org/en/blog/author/comunica-wp/rich600338<blockquote class="wp-embedded-content" data-secret="a6lEMTEGjz"><a href="https://leitat.org/en/blog/developing-molecular-signatures-for-s100-proteins/">Developing molecular signatures for S100 proteins</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://leitat.org/en/blog/developing-molecular-signatures-for-s100-proteins/embed/#?secret=a6lEMTEGjz" width="600" height="338" title="“Developing molecular signatures for S100 proteins” — Leitat Technological Center" data-secret="a6lEMTEGjz" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://leitat.org/wp-includes/js/wp-embed.min.js </script> https://leitat.org/wp-content/uploads/2020/01/LABORATORI-DE-CULTIU-CELULAR-031.jpg1440960The CDTI has granted two new loans to Atrys in the Cervera framework, in the field of liquid biopsy and AI applied to diagnostic imaging. The Cervera projects aim to help individual R&D projects developed by companies that collaborate with state-level Technology Centers, such as Leitat, in priority technologies. The financing, which represents 85% of […]